Health Condition 1: L501- Idiopathic urticaria
Conditions
Interventions
Intervention1: Cyclosporine and Levocetirizine: In this study we are going to give levocetirizine and cyclosporine to patients suffering from chronic spontaneous urticaria for study of the efficacy an
Sponsors
DR SAKSHAM MEHTA
Eligibility
Inclusion criteria
Inclusion criteria: All patients above 15 years of age will be included in the study. Cases willing to give informed consent/ assent as the case may be. All patients with a clinical diagnosis of chronic spontaneous urticaria for more than 6 months duration not responding to conventional lines of treatment will be included in the study. Patients with UAS-7 score more than 16 will be included in the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At the end of the study, the efficacy of low dose cyclosporine with levocetirizine and of levocetirizine alone in management of chronic spontaneous urticaria will be ascertained. Further a comparison between the two modalities in terms of efficacy and safety will be better understood.Timepoint: At the end of the study, the efficacy of low dose cyclosporine with levocetirizine and of levocetirizine alone in management of chronic spontaneous urticaria will be ascertained. Further a comparison between the two modalities in terms of efficacy and safety will be better understood. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: | — |
Countries
India
Contacts
Public ContactSAKSHAM MEHTA
SUMANDEEP VIDYAPEETH DEEMED TO BE UNIVERSITY
Outcome results
None listed